Lancet (London, England) LANCET RECOVERY Collaborative Group 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) a randomised controlled, open-label, platform trial ', The Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Mumford, A D 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised controlled, open-label, platform trial ', Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Group, RECOVERY C & Dark, P 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. ', Lancet (London, England), vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7
McAuley, D 2020, ' Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19:The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial ', JAMA : the journal of the American Medical Association . https://doi.org/10.1001/jama.2020.17022 JAMA : the journal of the American Medical Association Jama : Journal of the American Medical Association, 324, 1317-1329 Angus, D & Bradbury, C A 2020, ' Effect of Hydrocortisone on Mortality and Organ Support in Patients with Severe COVID-19 : The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial ', JAMA-Journal of the American Medical Association, vol. 324, no. 13, pp. 1317-1329 . https://doi.org/10.1001/jama.2020.17022 Jama : Journal of the American Medical Association, 324, 13, pp. 1317-1329 JAMA Writing Committee for the REMAP-CAP Investigators 2020, ' Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 : The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial ', JAMA, vol. 324, no. 13, pp. 1317-1329 . https://doi.org/10.1001/jama.2020.17022 JAMA, 324(13), 1317-1329. American Medical Association